There have been several updates to various areas of cardiology in 2015 and 2016. Landmark studies have been published and cardiology guidelines updated. The purpose of this article is to update you on this new information and help you apply them to your practice. We will be covering hypertension, lipids, aspirin, dual antiplatelet therapy and heart failure.
After participating in this activity, the pharmacist will be able to:
- Apply new clinical information from the HOPE-3 and SPRINT trials for treatment of blood pressure and dyslipidemia.
- Use nonstatin lipid-lowering therapies appropriately, including PCSK9 inhibitors, according to the 2016 ACC nonstatin clinical decision pathways.
- Identify which patients should be treated with aspirin for primary prevention of cardiovascular disease according to the 2016 U.S. Preventive Services Task Force recommendations.
- Identify the appropriate length of dual antiplatelet therapy for patients with coronary artery disease according to the 2016 ACC/AHA focused update.
- Appropriately select patients for treatment with new heart failure therapies according to the 2016 ACC/AHA/HFSA focused update on heart failure.
Activity type: Application-based
Target Audience: Pharmacists
Learning Level: 2
The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is approved for 2.0 contact hour of CPE credit (0.20 CEUs). The ACPE Universal Activity Number for this activity is 0202-0000-16-197-H04-P
To obtain 2.0 contact hours of continuing pharmacy education credit (0.2 CEUs) for completing "Cardiology Update: 2016," complete the CPE examination and evaluation questions. Credit will be awarded upon achieving a passing grade of 70% or better. Please visit CPE Monitor for your statement of credit/transcript.
APhA continuing pharmacy education policy provides you with two opportunities to successfully complete this continuing pharmacy education examination. Please note that you will not be permitted to submit the examination a third time. Exam questions may not appear in the same order as printed. The current policy of the APhA Education Department is not to release the correct answers to any of our CPE tests. This policy is intended to maintain the integrity of the CPE activity and the test. Individuals completing this activity by December 1, 2019 can receive credit.
Initial release date: December 1, 2016
Expiration date: December 1, 2019 - NO CREDIT GRANTED AFTER THIS DATE
"Cardiology Update: 2016” is a home-study continuing education activity for pharmacists developed by the American Pharmacists Association.
Dr. Evan Sisson, Pharm, PharmD, MSHA, CDE, FAADE
VA Commonwealth University School of Pharmacy
Dr. Evan Sisson, Pharm, PharmD, MSHA, CDE, FAADE declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria..
APhA’s editorial staff declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For a complete list of APhA staff disclosures, please visit the APhA website at www.pharmacist.com/apha-disclosures.
There is no fee associated with this activity for members of the American Pharmacists Association. There is a $25 fee for nonmembers.
Computer and Internet access is required to complete this activity. Please visit our website to view the System Requirements to have a positive learning experience.
|Activity Number||Credit Amount||Accreditation Period|
|ACPE# 0202-0000-16-197-H04-P||0.2 CEUs||December 01, 2016 - December 01, 2019|